2024-11-16 2025-11-30 false Capium Accounts Production 1.1 16083849 2024-11-16 2025-11-30 16083849 bus:FullAccounts 2024-11-16 2025-11-30 16083849 bus:Micro-entities 2024-11-16 2025-11-30 16083849 bus:AuditExemptWithAccountantsReport 2024-11-16 2025-11-30 16083849 bus:SmallCompaniesRegimeForAccounts 2024-11-16 2025-11-30 16083849 bus:PrivateLimitedCompanyLtd 2024-11-16 2025-11-30 16083849 2024-11-16 2025-11-30 16083849 2025-11-30 16083849 bus:RegisteredOffice 2024-11-16 2025-11-30 16083849 core:WithinOneYear 2025-11-30 16083849 core:AfterOneYear 2025-11-30 16083849 1 2024-11-16 2025-11-30 16083849 bus:Director1 2024-11-16 2025-11-30 16083849 bus:Director1 2025-11-30 16083849 bus:Director2 2024-11-16 2025-11-30 16083849 bus:Director2 2025-11-30 16083849 2023-11-16 16083849 bus:LeadAgentIfApplicable 2024-11-16 2025-11-30 16083849 2024-11-15 16083849 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 16083849 core:CostValuation core:Non-currentFinancialInstruments 2024-11-15 16083849 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 16083849 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16083849 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16083849 core:Non-currentFinancialInstruments 2025-11-30 16083849 core:Non-currentFinancialInstruments 2024-11-15 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 16083849
England and Wales
ADVANCED CARDIOVASCULAR CARE LTD
Unaudited Financial Statements
Period of accounts Start date: 16 November 2024 End date: 30 November 2025

ADVANCED CARDIOVASCULAR CARE LTD Company Information For the Period 16 November 2024 to 30 November 2025
Directors | Fatma ELSAYED Alaaeldin AMIN
Registered Number | 16083849
Registered Office | 3 Wilmin Grove Loughton Milton Keynes MK5 8EU
Accountants | AMMAR & CO Accountants Ltd Woods House 7 Gatliff Road London SW1W 8DE
1

ADVANCED CARDIOVASCULAR CARE LTD Balance Sheet As at 30 November 2025
|  | 2025
--- | --- | ---
|  | £ | £
Called up share capital not paid |  |  | 100
Current assets |  | 33,223 |
Creditors: amount falling due within one year |  | (11,482) |
Net current assets |  |  | 21,741
Total assets less current liabilities |  |  | 21,841
Net assets |  |  | 21,841
Capital and reserves |  |  | 21,841
NOTES TO THE ACCOUNTS General Information ADVANCED CARDIOVASCULAR CARE LTD is a private company, limited by shares, registered in England and Wales, registration number 16083849, registration address 3 Wilmin Grove, Loughton, Milton Keynes, MK5 8EU. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Dividends Proposed dividends are only included as liabilities in the balance sheet when their payment has been approved by the shareholders prior to the balance sheet date.
2. | Average number of employees Average number of employees during the period was 2.
For the period ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the companies act 2006 relating to small companies. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. Directors' Responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. The financial statements were approved by the board of directors on 12 January 2026 and were signed on its behalf by:
-------------------------------- Alaaeldin AMIN Director
2